Filing Details

Accession Number:
0001179110-11-003905
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-02 17:04:00
Reporting Period:
2011-02-28
Filing Date:
2011-03-02
Accepted Time:
2011-03-02 17:04:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1474632 Carlos Alban 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2011-02-28 7,000 $0.00 105,273 No 4 A Direct
Common Shares Without Par Value Disposition 2011-02-28 5,374 $47.64 99,899 No 4 F Direct
Common Shares Without Par Value Disposition 2011-02-28 810 $48.01 99,089 No 4 S Direct
Common Shares Without Par Value Disposition 2011-02-28 5,883 $47.99 93,206 No 4 S Direct
Common Shares Without Par Value Disposition 2011-02-28 700 $47.99 92,506 No 4 S Direct
Common Shares Without Par Value Disposition 2011-02-28 2,100 $48.00 90,406 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 660 Indirect Profit Sharing Trust (U.S.)
Common Shares Without Par Value 135 Indirect Profit Sharing Trust (Puerto Rico)
Footnotes
  1. Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
  2. Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2011.